Patent Cooperation Treaty

Numinus Wellness Inc. Reports Q4 2022 and Annual Results

Retrieved on: 
Tuesday, November 29, 2022
Mental health, Growth, Patent Cooperation Treaty, KAT, United Kingdom, TSX, WIPO, Transcranial magnetic stimulation, Corporation, First Nations in Ontario, CCR, PCT, Patient, United Nations, Fungus, Psilocybe, File, Patent, World Intellectual Property Organization, Ketamine, National Association Medical Staff Services, Research, Psilocybin, TMS, Esketamine, Acquisition, Medicine, Video game, Medical device, Management, Pharmaceutical industry, Health insurance, List of cosmic entities in Marvel Comics

VANCOUVER, BC, Nov. 29, 2022 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced its financial results for the three and twelve months ended August 31, 2022 ("Q4 2022" and "Fiscal 2022").

Key Points: 
  • VANCOUVER, BC, Nov. 29, 2022 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced its financial results for the three and twelve months ended August 31, 2022 ("Q4 2022" and "Fiscal 2022").
  • Revenues grew 643% year-over-year to $4.2 million in Q4 2022, due primarily to the acquisition of Novamind.
  • On June 27, 2022, Numinus introduced its new logo and brand identity to unify Numinus' presence across North America.
  • At the end of Q4 2022, Numinus had 122 practitioners providing client treatments through its wellness clinics and virtual services, a 10% increase from the beginning of the quarter.

Tetra Bio-Pharma Provides Update on Patent Applications for Novel Therapeutic ARDS-003

Retrieved on: 
Tuesday, November 29, 2022
IP, FIH, TSX, Multimedia, PCT, United States Patent and Trademark Office, End organ damage, Pain, Safety, Insurance, Physician, Patent Cooperation Treaty, Solubility, Patient, Legislation, Plasma protein binding, Inflammation, Composition, Patent, TBP, News, COVID, Research, HU308, Sepsis, FRA, FDA, Generic drug, Pharmaceutical industry, Tetra

Tetra strengthens its intellectual property position with PCT and provisional patent applications for its innovative therapeutic, ARDS-003.

Key Points: 
  • Tetra strengthens its intellectual property position with PCT and provisional patent applications for its innovative therapeutic, ARDS-003.
  • MONTREAL, Nov. 29, 2022 /PRNewswire/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery and development today announced the filing of three patent applications for its novel therapeutic, ARDS-003.
  • The Company filed a provisional patent application with the United States Patent and Trademark Office related to crystalline Onternabez and uses thereof.
  • Guy Chamberland, CEO and Chief Regulatory Officer at Tetra commented "This is a significant step in protecting our novel therapeutic, ARDS-003.

Northstar Reports Third Quarter 2023 Financial Results

Retrieved on: 
Thursday, November 24, 2022
URL, Quarter, United States patent law, Colas, COVID-19, US Custom House (Nogales, Arizona), Letter, Webcast, Legislation, Empower, Patent, Q&A, SEDAR, United States Patent and Trademark Office, Risk, Prospectus, Patent Cooperation Treaty, Collection, EST, Pacific Northwest, Multimedia, PST, Customer, Renewable energy, Asphalt, Borosilicate glass, Metro Vancouver Regional District

The Company has scheduled a virtual investor webcast to discuss these financial results and to provide a business update to the investment community later today, Wednesday, November 23, 2022, at 2:00 pm PST / 5:00 pm EST.

Key Points: 
  • The Company has scheduled a virtual investor webcast to discuss these financial results and to provide a business update to the investment community later today, Wednesday, November 23, 2022, at 2:00 pm PST / 5:00 pm EST.
  • Mr. Aidan Mills, President & CEO and Director of Northstar, commented, "The third quarter of 2022 was one of our busiest quarters to date.
  • November 2022 Announced a corporate and intellectual property update, and the details of the Q3 2022 financial results webcast.
  • Northstar Clean Technologies Inc. is a Canadian-based clean technology company focused on the sustainable recovery and reprocessing of asphalt shingles.

Northstar Awarded Patent by United States Patent and Trademark Office Protecting Its Front-end Process for Reprocessing Asphalt Shingles

Retrieved on: 
Tuesday, November 8, 2022
Risk, Patent, Legislation, Company, Board, Director, United States Patent and Trademark Office, Forward-looking statement, SEDAR, Prospectus, View, Patent Cooperation Treaty, Multimedia, Intellectual property, CEO, Asphalt, Borosilicate glass, Risk management, BC

VANCOUVER, BC, Nov. 8, 2022 /PRNewswire/ - Northstar Clean Technologies Inc. (TSXV: ROOF) (OTCQB: ROOOF) ("Northstar" or the "Company") is pleased to announce that it has been issued a patent for the Company's front-end technology for reprocessing asphalt shingles by the United States Patent and Trademark Office ("USPTO").

Key Points: 
  • VANCOUVER, BC, Nov. 8, 2022 /PRNewswire/ - Northstar Clean Technologies Inc. (TSXV: ROOF) (OTCQB: ROOOF) ("Northstar" or the "Company") is pleased to announce that it has been issued a patent for the Company's front-end technology for reprocessing asphalt shingles by the United States Patent and Trademark Office ("USPTO").
  • We are delighted to be issued our first patent from the USPTO for the front-end of our proprietary technology for reprocessing asphalt roofing shingles.
  • This patent further strengthens Northstar's mission to be the leader in the recovery and reprocessing of asphalt shingles in North America."
  • Northstar Clean Technologies Inc. is a Canadian-based clean technology company focused on the sustainable recovery and reprocessing of asphalt shingles.

ABVC BioPharma Receives Notice of Allowance from US Patent and Trademark Office for ABV-1504 Used to Treat Major Depressive Disorder (MDD)

Retrieved on: 
Monday, November 7, 2022
San Francisco, Company, European Patent Convention, Polygala, CA, Stanford University, Patent, CAGR, Risk, University of California, San Francisco, GLOBE, PCT, EPO, European Patent Office, Cedars-Sinai Medical Center, Patent Cooperation Treaty, United States patent law, University, CNS, U.S. Securities and Exchange Commission, Forward-looking statement, USD, NASDAQ, Ophthalmology, Technology, Security (finance), SEC, Treatment, Pharmaceutical industry

The patent, entitled Polygala Extract for the Treatment of Major Depressive Disorder, outlines a method for treating major depressive disorder by oral administration of a composition, ABV-1504, containing Radix Polygalae (Polygala tenuifolia Willd).

Key Points: 
  • The patent, entitled Polygala Extract for the Treatment of Major Depressive Disorder, outlines a method for treating major depressive disorder by oral administration of a composition, ABV-1504, containing Radix Polygalae (Polygala tenuifolia Willd).
  • In addition to the United States, the patent was also filed in China, Taiwan and under the Patent Cooperation Treaty (PCT).
  • The PCT patent application was published on January 27, 2022, and subsequently was filed in Japan, Australia and with the European Patent Office (EPO).
  • The new patent substantially extends the existing patent life ofABV-1504 to the year 2041 in the US, said Dr. Howard Doong, ABVC chief executive officer.

Israeli Cannabis Technology Company BYND Cannasoft Enterprises Provides Update on International Patent Application Process for its Revolutionary EZ-G Device

Retrieved on: 
Thursday, November 3, 2022
ISA, Patent Prosecution Highway, Company, Research, International, Ministry, CSE, Patent, Invention, Industry, Dry, GLOBE, Intellectual property, PCT, Patent Cooperation Treaty, Cannabis, Marketing, Income, CEO, Pharmacy, CBD, BYND, CRM, NASDAQ, B2C, BCAN, Acquisition, Human, BETA, SEDAR, Software, PPH, Examiner, Program, Female, 3D printing, Drug, Investment

BYND Cannasoft can now accelerate the examination of its present application in some jurisdictions, such as the US and Israel, as part of a PCT-PPH program .

Key Points: 
  • BYND Cannasoft can now accelerate the examination of its present application in some jurisdictions, such as the US and Israel, as part of a PCT-PPH program .
  • In September, BYND Cannasoft completed its acquisition of Zigi Carmel Initiatives & Investments Ltd., which holds the intellectual property for the patent-pending EZ-G device.
  • At that time, BYND Cannasoft announced plans to pursue the patent and establish a marketing and sales system for the EZ-G device based on B2B and B2C sales.
  • Since BYND Cannasoft purchased Zigi Carmel Initiatives & Investments, I have been committed to bringing the EZ-G device to market as quickly as possible.

INEO Achieves 67% Revenue Increase for Fiscal 2022

Retrieved on: 
Tuesday, October 25, 2022
Traction, Media Network, Pharmacy, GATE, E-commerce, Technology, Patent Cooperation Treaty, Growth, EAS, Agreement, Intellectual property, Partnership, Conversation, Company, Industry, Founder, CEO, Ecosystem, Social media, Electronic article surveillance, Patent, Advertising, Management, Electronic article, EBITDA, EVO, Pedestal, Solution, DUO, DOOH, Online gambling, Video game, Cryptocurrency, Warehouse, Airline, Marketing, BC, Prosegur, Western media

INEO achieved 67% increase in year-over-year revenue and 74% increase in gross profit for fiscal 2022 ended June 30, 2022.

Key Points: 
  • INEO achieved 67% increase in year-over-year revenue and 74% increase in gross profit for fiscal 2022 ended June 30, 2022.
  • "We are very pleased with our fiscal 2022 annual results in which we reported a 67% increase in revenue and a 74% increase in gross profit," said Greg Watkin, Chairman and Founder of INEO.
  • INEO generated $1,245,095 of revenue for the year ended June 30, 2022, representing an increase of 67% as compared to revenue of $745,160 for the year ended June 30, 2021.
  • Revenue for Q4-2022 for the three months ending June 30, 2022 was $413,869 an increase of 93% compared to revenue of $214,253 Q4-2021.

INEO Extends Intellectual Property Protection with Global Patent Cooperation Treaty

Retrieved on: 
Wednesday, October 19, 2022
TSX Venture Exchange, GATE, IOT, Patent Cooperation Treaty, PCT, AM, Housing, Software as a service, Solution, EAS, Digital media, Technology, Company, Industry, RF, AI, Internet, Patent, Electronic article surveillance, Advertising, Artificial intelligence, Electronic article, Lead, Television, Video game, BC, Prosegur

SURREY, BC, Oct. 19, 2022 /PRNewswire/ - INEO Tech Corp. (TSXV: INEO) (OTCQB: INEOF) (the "Company" or "INEO"), the innovative developer and operator of the INEO Media Network, a digital advertising and analytics solution for retailers, today announced it made a Patent Cooperation Treaty (PCT) filing for global intellectual property protection.

Key Points: 
  • SURREY, BC, Oct. 19, 2022 /PRNewswire/ - INEO Tech Corp. (TSXV: INEO) (OTCQB: INEOF) (the "Company" or "INEO"), the innovative developer and operator of the INEO Media Network, a digital advertising and analytics solution for retailers, today announced it made a Patent Cooperation Treaty (PCT) filing for global intellectual property protection.
  • INEO recently filed for a design patent in Canada for its "INEO WELCOMING GATE" system, a companion system to the INEO Welcoming Pedestal.
  • This patent has now been extended with a global priority filing to include the United States and Europe.
  • "INEO's intellectual property strategy is keeping us in an industry leading position which is far ahead of the competition," said Greg Watkin, Chairman and President of INEO.

Industrial Nanotech, Inc. Announces SteelTile™ for High Temperature Steel Mill Furnaces

Retrieved on: 
Wednesday, October 12, 2022
Pink, British Steel, Climate, Temperature, Company, Industry, U.S. Steel, Steel, GLOBE, World War II, CTO, Patent Cooperation Treaty, Iron ore

BROOMFIELD, Colo., Oct. 12, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Industrial Nanotech, Inc.(Pink Sheets: INTK) , a global nanoscience solutions and research leader, today announced that the Company is launching SteelTile (US & International Patents Pending), a new extreme high-temperature thermal insulation product for use on steel mill furnaces and other extreme high temperature, energy-intensive industrial equipment.

Key Points: 
  • BROOMFIELD, Colo., Oct. 12, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Industrial Nanotech, Inc.(Pink Sheets: INTK) , a global nanoscience solutions and research leader, today announced that the Company is launching SteelTile (US & International Patents Pending), a new extreme high-temperature thermal insulation product for use on steel mill furnaces and other extreme high temperature, energy-intensive industrial equipment.
  • The US steel manufacturing industry has been one of the leading industries focused on reducing the amount of energy used to make their products.
  • UK steelmaker British Steel said the spiraling energy bills cannot be absorbed and are putting the UK steel industry at a significant competitive disadvantage.
  • The Companys first specification, prepared for US Steel, shows an annual energy savings of $1,722,220.81 for just one of their large steel mill furnaces.

Go Green Global Technologies Corp. Announces Updated Patent Applications and Filings

Retrieved on: 
Monday, October 10, 2022
Method, Sale, Patent Cooperation Treaty, PCT, Corrosion, Transport, Pulsed-power water treatment, Hercules, Technology, Private Securities Litigation Reform Act, Go Green Wilmette, Mission statement, Company, Marketing, CEO, Water, Burn, Sonic Movement, Patent, OTC, Federation, Forward-looking statement, Solution, Language, Renewable energy

Today, the Company announces that as of September 10, 2022, it has completed the PCT (Patent Cooperation Treaty) application for its water and fuel treatment apparatus, the Sonical system.

Key Points: 
  • Today, the Company announces that as of September 10, 2022, it has completed the PCT (Patent Cooperation Treaty) application for its water and fuel treatment apparatus, the Sonical system.
  • This patent application gives the Company and its shareholders greater potential in the international markets for future sale of its products world-wide.
  • Go Green Global Technologies Corp. is an innovative publicly traded U.S. company that provides industry-disruptive technology for a variety of water and fuel use applications.
  • For additional information please contact:
    Go Green Global Technologies Corp.